Calibrate
by Calibrate
· Based in United States →
— The Metabolic Approach to Sustainable Weight Loss
$199/month
Overview
Calibrate is a telehealth platform focused on metabolic health and sustainable weight loss. It combines clinician-prescribed GLP-1 (glucagon-like peptide-1) or GIP/GLP-1 medications with a structured lifestyle intervention program.
- What it does: Calibrate provides a “Metabolic Reset” program that includes virtual 1:1 coaching, a science-backed curriculum focusing on food, sleep, exercise, and emotional health, and access to GLP-1 or GIP/GLP-1 medications prescribed by Calibrate clinicians. The program aims to help individuals achieve weight loss and improve metabolic health.
- Who it is for: Calibrate is for adults (18 years or older) with a BMI of 30 or higher, or a BMI of 27 or higher with one or more metabolic conditions such as pre-diabetes, high cholesterol, high blood pressure, cardiovascular disease, non-alcoholic fatty liver disease, obstructive sleep apnea, or PCOS. It is not for individuals who are pregnant, breastfeeding, or planning to become pregnant within one to two years, or those with certain medical conditions like active eating disorders, recent bariatric surgery, or a history of medullary thyroid cancer.
- How it fits a clinical or practice workflow: Patients enroll in Calibrate, often through employer-sponsored health plans. The workflow involves an initial health intake, lab work (which can be uploaded or ordered by Calibrate), and a virtual consultation with a Calibrate clinician to establish a treatment plan, including medication if appropriate. Members then engage in bi-weekly 15-minute video coaching sessions and follow a curriculum via the Calibrate app, which also serves for tracking progress and communicating with the support team. Calibrate states they can coordinate treatment plans with a member’s primary care provider or specialists.
- Notable capabilities: The program emphasizes a combination of GLP-1 or GIP/GLP-1 medication with intensive lifestyle intervention. Calibrate clinicians are US-licensed and board-certified. The program includes a smart scale that connects to the Calibrate app for tracking.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Clinician-prescribed GLP-1 medication
- 1:1 video coaching
- Science-backed reading lessons
- Metabolic monitoring
- Behavioral change curriculum
- Employer coverage options
- Focus on metabolic health
- Sustained weight loss results (20% average over 3 years)
Use Cases
- Sustainable weight loss for individuals
- Metabolic health improvement
- Obesity management
- Employer-sponsored wellness programs
What Physicians Need to Know
Key Capabilities
Calibrate offers a year-long telehealth program focused on metabolic health, combining GLP-1 medication prescriptions with structured coaching and education. It aims to deliver multi-year improvements in weight and cardiometabolic health, with or without GLP-1 medications. The program includes personalized care plans, 1:1 video coaching, and a science-based curriculum covering food, exercise, sleep, and mindset. Calibrate also provides tools for employers to manage GLP-1 costs and improve obesity outcomes for their employees.
Clinical Utility
Calibrate's program is designed to treat obesity comprehensively, addressing underlying biology and supporting long-term results. It's particularly aimed at adults meeting medical criteria for GLP-1 medications (BMI of 30 or higher, or 27+ with weight-related health conditions). The program emphasizes sustained weight loss and cardiometabolic improvements, with reported averages of 19% weight loss over three years.
Integration Options
Calibrate's program involves lab work completed at local Quest or LabCorp facilities, with a primary care provider, or another healthcare facility. It also integrates with a smart scale that connects directly to the Calibrate app for tracking progress.
Compliance Status
Calibrate's clinicians are US-licensed and board-certified, with many having extensive backgrounds in obesity medicine. The company states that its clinicians follow evidence-based protocols aligned with American Board of Obesity Medicine standards. The program's enrollment process is designed by physician experts to ensure clinical appropriateness for their treatment model.
Pricing Model
Calibrate operates on a subscription basis, with individual plans starting around $199/month with a 3-month minimum. This fee typically covers provider access and ongoing management. Medications and lab work are billed separately through insurance, and Calibrate assists with insurance navigation and prior authorizations. Employer-sponsored plans may cover the cost for employees and dependents.
User Experience
The program involves an initial eligibility screening, a comprehensive health intake form, required metabolic lab work, and a virtual appointment with a Calibrate clinician. Members have 1:1 video coaching sessions, access to a science-based curriculum, and can communicate with their medical team asynchronously through the Calibrate app. A smart scale is provided to members to sync with the app.
Support Quality
Calibrate provides continuous monitoring and support from a medical team of doctors and nurses who follow member progress and oversee care. Members have access to their medical team for asynchronous questions or to schedule additional calls and video visits through the dedicated Medical Channel in the Calibrate app.
Implementation Complexity
The program requires an initial eligibility quiz, comprehensive health intake, lab work, and a virtual clinician visit. Members need to complete labs at a local facility and ensure they are physically located in their state of residence for virtual appointments.
Evidence Base
Calibrate is backed by over five years of real-world outcomes and clinical data demonstrating sustained weight loss with cardiometabolic improvements. The program's curriculum is evidence-based, and its approach combines medication with transformative behavior change. Calibrate has been recognized by organizations like the World Economic Forum's Technology Pioneers and Fast Company's World Changing Ideas.
Physician Tip
When considering Calibrate for patients, note that it's a comprehensive, clinician-led program for obesity management that integrates GLP-1 medications with significant lifestyle intervention. It's crucial to ensure patients meet the specific eligibility criteria, including BMI and metabolic conditions, and are committed to the year-long program with its coaching and curriculum. Advise patients that while the program fee is separate, Calibrate assists with insurance navigation for medications and labs. Emphasize the importance of completing required lab work and being prepared for virtual clinician visits. For patients already on GLP-1s, understand that Calibrate's model may require them to enroll in their program to access the medication through certain employer plans.
Calibrate's primary integrations involve external lab services (Quest, LabCorp, or other healthcare facilities) for required metabolic lab work and a smart scale that syncs with their dedicated app for progress tracking. While the platform itself is a self-contained telehealth program, the need for external lab work and the integrated scale are key components of its operational flow.
Details
| Category | Endocrinology & Metabolic AI, Patient Engagement & Education |
| Pricing | $199/month — Starting at $199/month for individuals; employer-covered options available |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated Calibrate clinicians prescribe FDA-approved GLP-1 medications when clinically appropriate. The platform itself is not an FDA-cleared medical device. |
| Integrations | |
| EHR | Not specified |
| Specialties | Endocrinology, Family Medicine, Internal Medicine |
What the Web Says
Calibrate is a digital metabolic health company that offers a one-year program combining GLP-1 medication with 1:1 accountability coaching and a curriculum focused on food, sleep, exercise, and emotional health. The program aims to help individuals achieve sustainable weight loss and improve overall metabolic health by addressing the underlying biology of weight. While many users report significant weight loss and positive lifestyle changes, there are also numerous complaints regarding customer service, medication access, and communication issues.
Overall: MixedStrengths
- Combines GLP-1 medication with lifestyle coaching for a holistic approach.
- Many users report significant and sustainable weight loss (average 15%).
- Focuses on long-term metabolic health rather than quick fixes.
- Provides personalized support from health coaches.
- Curriculum is easy to understand and promotes gradual, sustainable changes.
- Offers a money-back guarantee for 10% weight loss, though terms apply.
Limitations
- Frequent complaints about poor customer service and slow response times.
- Issues with obtaining and refilling GLP-1 medications, including insurance coverage and supply shortages.
- The app can be confusing and have usability issues.
- Some users find the program expensive, especially if medication isn't covered by insurance.
- Disorganization and lack of communication from the Calibrate team.
- Coaches are not always healthcare professionals.
Based on reviews from: G2, Reddit, Capterra, Trustpilot, Everyday Health, Forbes, FinvsFin, Indeed.com, Consumer Affairs, Healthline
Last updated: 2026-07-27
Ratings & Reviews
Rate Calibrate
Press & Coverage
PR Newswire
Calibrate Publishes Largest Real-World Four-Year Analysis of GLP-1 Weight Loss Outcomes When Paired with Integrated Behavioral Support
Calibrate released its 2026 Results Report, showcasing a four-year analysis of GLP-1 weight loss outcomes combined with behavioral support, drawing on data from over 50,000 members. The report highlights sustained weight loss of 16% at year one, increasing to 21% by year four, particularly in high-risk populations.
2026-05
Calibrate
Calibrate Completes Transition to Enterprise-Focused Obesity Management, More Than Doubles Client Roster
Calibrate announced its full transition from a direct-to-consumer model to an enterprise-focused solution for obesity management, serving employers, health plans, and channel partners. This shift has led to a doubling of its client base and is expected to result in profitability for the first time.
2026-02
Calibrate
How Employers Can Finally Take Control of GLP-1 Costs: A New Model for Sustainable Access
This article discusses a new model for employers to manage GLP-1 costs sustainably, emphasizing Calibrate's integrated approach to obesity treatment. It highlights how Calibrate's program helps control medication expenses while delivering long-term weight loss and improved metabolic health.
2026-01
Calibrate
Calibrate Unveils Fourth Annual Results Report
Calibrate's fourth annual Results Report showcases sustained weight loss and metabolic health improvements, with members achieving 19% average sustained weight loss at 36 months. The report emphasizes the program's integrated approach, combining GLP-1 medications with Intensive Lifestyle Intervention.
2025-01
Calibrate
Transforming Workplace Health: Calibrate Results Demonstrate the Significance of a BMI of <25
Presented at Obesity Week 2024, Calibrate's research highlights how its program helps members achieve a healthy BMI of less than 25, reducing metabolic health risks and delivering measurable business outcomes for employers. The program focuses on intensive lifestyle interventions alongside medication.
2024-11
Calibrate
Research Recap: GLP-1 Access & Clinical Outcomes for Obesity Treatment
Calibrate presented research at the 2024 Endocrine Society meeting, analyzing outcomes from over 7,600 members, showing an average weight loss of 16.2% at 12 months. The study also addressed the impact of GLP-1 medication access challenges on patient results.
2024-08
Calibrate
Validation Institute Certifies Calibrate's Metabolic Reset Program
Validation Institute has verified Calibrate's Metabolic Reset program, confirming that participants, on average, lose weight, reduce waist circumference, and can successfully taper off weight loss medications while maintaining clinically significant weight loss. This certification follows Calibrate's Third Annual Results Report.
2024-03
Business Wire
Calibrate Sets New Benchmark in Obesity Treatment: Demonstrates a Remarkable 18% Sustained Weight Loss for Members at 24 Months, Outperforming GLP-1 Medication Trials
Calibrate announced groundbreaking results from its largest real-world member cohort, showing an average of 16.2% weight loss at 12 months and 17.9% at 24 months, surpassing outcomes observed in GLP-1 medication clinical trials. The report includes data on over 16,000 members.
2024-01
Videos
Product demos, reviews, and walkthroughs for Calibrate.
Loading videos...
Frequently Asked Questions
Calibrate primarily uses AI to enhance the member experience by tracking progress and addressing non-clinical concerns. While AI is not yet directly used on the clinical side for prescribing, there's potential for future integration in medication tracking and reducing risks associated with multiple prescriptions. For endocrinology, AI's role in analyzing physiological data, biomarkers, and identifying patterns could lead to personalized exercise recommendations and insights into metabolic efficiency and disease prevention.
Calibrate reports that approximately 81% of members completed their one-year program, and 70% enrolled for a second year. The program combines GLP-1 medication with biweekly video coaching and a curriculum focusing on food, sleep, exercise, and emotional health to support adherence and sustained weight loss.
Alternatives to Calibrate include other telehealth GLP-1 programs like FormBlends, Hims & Hers, Ro Body, and TrimRx, as well as direct-to-pharmacy compounded options. These alternatives often differ in pricing models (some include medication, others separate), the extent of coaching services, and whether they offer brand-name or compounded GLP-1 medications.
Calibrate's annual program fee typically ranges from $1,649 to $1,999, which covers coaching, clinician visits, and insurance coordination, but *not* the medication itself. Medication costs are separate and depend on insurance coverage; with strong commercial insurance, GLP-1 copays can be around $25 per month, but without insurance, brand-name GLP-1s can exceed $1,000 monthly.
Calibrate is limited to individuals aged 18-64 with commercial or employer insurance and a BMI meeting specific criteria (30+, or 27+ with a weight-related condition). The program primarily prescribes GLP-1 receptor agonists, which may limit options for patients with contraindications or those who don't tolerate these medications. Additionally, while the program is one year, obesity often requires long-term treatment, and patients discontinuing Calibrate may lose access to their prescribing clinician.
Suggest an Edit →
| Last Verified: 2026-07-26 | First Added: 2026-07-26
Investors who backed Calibrate
Funded through the company that built this tool.
